WHO ICTRP trial

Optimising Management of acute pain in Opioid Substitution Therapy patients: A…

ACTRN12612000288820 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12612000288820
Public title Optimising Management of acute pain in Opioid Substitution Therapy patients: A pilot laboratory randomised study
Scientific title Optimising management of acute pain in opioid substitution therapy patients: A pilot laboratory randomised study.
Primary sponsor Sydney Local Health District - Royal Prince Alfred Hospital
Secondary sponsors South Eastern Sydney Local Health District - Langton Centre
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 3 / Phase 4
Countries Australia
Conditions Acute pain in opioid dependence; Acute pain in opioid dependence;Mental Health - Addiction;Anaesthesiology - Pain management
Interventions There are three participant groups. i) Participants on methadone ii) Participants on buprenorphine (or buprenorphine+naloxone) iii) A healthy control group. The procedures for the first two participant groups (those on methadone and those…
Registration date Dec 3, 2012
Target size 36
Secondary IDs Nil
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations